Health service costs and their association with functional impairment among adults receiving integrated mental health care in five low- and middle-income countries: the PRIME cohort study.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
01 Jun 2020
Historique:
accepted: 29 12 2019
pubmed: 10 3 2020
medline: 30 12 2020
entrez: 10 3 2020
Statut: ppublish

Résumé

This study examines the level and distribution of service costs-and their association with functional impairment at baseline and over time-for persons with mental disorder receiving integrated primary mental health care. The study was conducted over a 12-month follow-up period in five low- and middle-income countries participating in the Programme for Improving Mental health carE study (Ethiopia, India, Nepal, South Africa and Uganda). Data were drawn from a multi-country intervention cohort study, made up of adults identified by primary care providers as having alcohol use disorders, depression, psychosis and, in the three low-income countries, epilepsy. Health service, travel and time costs, including any out-of-pocket (OOP) expenditures by households, were calculated (in US dollars for the year 2015) and assessed at baseline as well as prospectively using linear regression for their association with functional impairment. Cohort samples were characterized by low levels of educational attainment (Ethiopia and Uganda) and/or high levels of unemployment (Nepal, South Africa and Uganda). Total health service costs per case for the 3 months preceding baseline assessment averaged more than US$20 in South Africa, $10 in Nepal and US$3-7 in Ethiopia, India and Uganda; OOP expenditures ranged from $2 per case in India to $16 in Ethiopia. Higher service costs and OOP expenditure were found to be associated with greater functional impairment in all five sites, but differences only reached statistical significance in Ethiopia and India for service costs and India and Uganda for OOP expenditure. At the 12-month assessment, following initiation of treatment, service costs and OOP expenditure were found to be lower in Ethiopia, South Africa and Uganda, but higher in India and Nepal. There was a pattern of greater reduction in service costs and OOP spending for those whose functional status had improved in all five sites, but this was only statistically significant in Nepal.

Identifiants

pubmed: 32150273
pii: 5801145
doi: 10.1093/heapol/czz182
doi:

Types de publication

Journal Article

Langues

eng

Pagination

567-576

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MR/M025470/1
Pays : United Kingdom

Informations de copyright

© World Health Organization 2020. All rights reserved. The World Health Organization has granted the Publisher permission for the reproduction of this article.

Auteurs

Dan Chisholm (D)

Department of Mental Health and Substance Abuse, World Health Organization, Avenue Appia 20, Geneva 1211, Switzerland.

Emily Garman (E)

Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University of Cape Town, 46 Sawkins Road, Rondebosch, 7700 Cape Town, South Africa.

Erica Breuer (E)

Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University of Cape Town, 46 Sawkins Road, Rondebosch, 7700 Cape Town, South Africa.

Abebaw Fekadu (A)

Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, SE5, London, UK.

Charlotte Hanlon (C)

Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, SE5, London, UK.
Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Arat Kilo, 1176, Addis Ababa, Ethiopia.

Mark Jordans (M)

Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, SE5, London, UK.

Tasneem Kathree (T)

School of Psychology, University of KwaZulu Natal, Umbilo Road, Congella 4013, Durban, South Africa.

Fred Kigozi (F)

Butabika Mental Hospital, Plot 2, Butabika Road, P.O. Box 7017, Kampala, Uganda.

Nagendra Luitel (N)

Transcultural Psychosocial Organization (TPO) Nepal, Baluwatar 44600, Kathmandu, Nepal.

Girmay Medhin (G)

Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Arat Kilo, 1176, Addis Ababa, Ethiopia.

Vaibhav Murhar (V)

Sangath, 120, Deepak Society, Chuna Bhatti, Bhopal, Madhya Pradesh 462016, India.

Inge Petersen (I)

School of Psychology, University of KwaZulu Natal, Umbilo Road, Congella 4013, Durban, South Africa.

Sujit D Rathod (SD)

Department of Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

Rahul Shidhaye (R)

Centre for Mental Health, Public Health Foundation of India, Unit No. 316, 3rd Floor, Rectangle -1 Building, Plot No. D-4, District Centre Saket, New Delhi-110017, India.

Joshua Ssebunnya (J)

Butabika Mental Hospital, Plot 2, Butabika Road, P.O. Box 7017, Kampala, Uganda.

Vikram Patel (V)

Centre for Mental Health, Public Health Foundation of India, Unit No. 316, 3rd Floor, Rectangle -1 Building, Plot No. D-4, District Centre Saket, New Delhi-110017, India.
Department of Global Health and Social Medicine, Harvard Medical School, 641 Huntington Avenue, Boston, MA 02115, USA.

Crick Lund (C)

Alan J Flisher Centre for Public Mental Health, Department of Psychiatry and Mental Health, University of Cape Town, 46 Sawkins Road, Rondebosch, 7700 Cape Town, South Africa.
Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, SE5, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH